1. DNA helicases and their roles in cancer
- Author
-
Arindam Datta, Srijita Dhar, and Robert M. Brosh
- Subjects
Genome instability ,DNA Replication ,DNA Repair ,DNA damage ,DNA repair ,Biochemistry ,Genomic Instability ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Neoplasms ,Animals ,Humans ,Molecular Biology ,030304 developmental biology ,0303 health sciences ,biology ,DNA Helicases ,Helicase ,Cell Biology ,Telomere ,Cell biology ,Helicase Gene ,chemistry ,030220 oncology & carcinogenesis ,Cancer cell ,biology.protein ,DNA - Abstract
DNA helicases, known for their fundamentally important roles in genomic stability, are high profile players in cancer. Not only are there monogenic helicase disorders with a strong disposition to cancer, it is well appreciated that helicase variants are associated with specific cancers (e.g., breast cancer). Flipping the coin, DNA helicases are frequently overexpressed in cancerous tissues and reduction in helicase gene expression results in reduced proliferation and growth capacity, as well as DNA damage induction and apoptosis of cancer cells. The seminal roles of helicases in the DNA damage and replication stress responses, as well as DNA repair pathways, validate their vital importance in cancer biology and suggest their potential values as targets in anti-cancer therapy. In recent years, many laboratories have characterized the specialized roles of helicase to resolve transcription-replication conflicts, maintain telomeres, mediate cell cycle checkpoints, remodel stalled replication forks, and regulate transcription. In vivo models, particularly mice, have been used to interrogate helicase function and serve as a bridge for preclinical studies that may lead to novel therapeutic approaches. In this review, we will summarize our current knowledge of DNA helicases and their roles in cancer, emphasizing the latest developments.
- Published
- 2020